YUKI GOSEI KOGYO CO.,LTD.YUKI GOSEI KOGYO CO.,LTD.

Corporate Profile
  • TOP
  • Company Information
  • Corporate Profile

Corporate Profile

Corporate name
YUKI GOSEI KOGYO CO., LTD.
Offices
Head Office, Business DivisionⅡ, Tokyo Research Laboratory, Joban Factory, Düsseldorf Office
Business Fields
・Pharmaceuticals
・Food additives
・Industrial chemicals
Capital
3,471 million yen (total number of issued shares: 21,974,000 shares)
Listed on the Tokyo Stock Exchange, Standard Market
Executives
(as of June 23, 2023)

President & CEO
Business Sector
Seiichiro Matsumoto

Director & Managing Executive Officer, Research & Development Sector, Manufacturing Sector
Masahiro Kusano

Director & Senior Executive Officer, Business Administration Sector
Tatsuya Komatsubara

Director, Audit & Supervisory Committee Member
Naotake Suto

Director, Audit & Supervisory Committee Member
Keisuke Yamada

Director, Audit & Supervisory Committee Member
Norito Ohori

Senior Executive Officer, General Manager, Business DivisionⅠ & Business Management Division
Masao Matsukawa

Executive Officer, General Manager, General Affairs & Human Resources Division
Hiromi Ishikawa

Executive Officer, General Manager, Joban Factory
Makoto Kito

Executive Officer, General Manager, Quality Assurance Division
Hiroshi Nakamura

Number of employees
(as of March 31, 2023)
295 (excluding loan, part-time and temporary employees)

Major banks
MUFG Bank, Ltd., Joyo Bank, Mitsubishi UFJ Trust and Banking Corporation, Mizuho Bank, Ltd.
Affiliated company
Yuki Techno Service Co., Ltd.

Organizational Chart

History

1947
Yuki Gosei Kogyo Kabushikigaisha (Yuki Gosei Kogyo Co., Ltd.) was established to produce flavors for tobacco

  • 1948
    Acquired Maeno Plant (later renamed“Maeno Office”)

  • 1952
    Started manufacture of glycine, isoniazid and nicotinic acid amide

  • 1958
    Started manufacture of beta-alanine and pinkmine

  • 1960
    Started manufacture of 2-vinylpyridine

  • 1961
    Started manufacture of glycine and beta-alanine using a new manufacturing method

  • 1962
    The company’s name in Japanese changed from“Yuki Gosei Kogyo Kabushikigaisha”to“Yuki Gosei Yakuhin Kogyo Kabushikigaisha”
    The Head Office moved to Takara-cho, Chuo-ku
    Listed on the Second Section of the Tokyo Stock Exchange

  • 1963
    Started manufacture of triacetin

  • 1964
    Started operation of Joban Plant
    Started manufacture of flavors for Peace cigarettes

  • 1965
    Started manufacture of protamine sulfate and flavors for mf cigarettes

  • 1966
    Started manufacture of leucic acid and flavors for Hi-lite cigarettes

  • 1967
    Started manufacture of nicotinic acid amide using a new manufacturing method
    Started manufacture of 3-cyanopyridine

  • 1968
    Started manufacture of 8-hydroxyquinoline and flavors for Seven Stars cigarettes

  • 1969
    Started manufacture of amino acid sugar (Yukisu)

  • 1970
    Started manufacture of flavors for Cherry cigarettes

  • 1971
    Started manufacture of glycine at new facilities

  • 1972
    Started manufacture of nicotinic acid amide at new facilities
    Tokyo Laboratory completed

  • 1973
    Started manufacture of iminodiacetic acid

  • 1975
    Started manufacture of intermediates for agricultural chemicals and picolinic acid

  • 1976
    Started manufacture of CP essence

  • 1977
    Started manufacture of 3-aminopyridine

  • 1978
    Started manufacture of DNA
    Activated sludge treatment facilities completed at Joban Plant

  • 1982
    Test plant facilities newly installed at Tokyo Laboratory

  • 1983
    Facilities for manufacturing flavors and materials for tobacco newly installed at Joban Plant

  • 1984
    Multi-purpose manufacturing facilities newly installed at Joban Plant

  • 1985
    Started manufacture of silicone-related products

  • 1986
    Started manufacture of 4-aminopyridine and isonicotinic acid

  • 1990
    Drug intermediate-purification facilities newly installed at Joban Plant
    Capital increased to 2,550 million yen

  • 1991
    The Head Office moved to Hirakawa-cho, Chiyoda-ku
    Manufacturing facilities for silicon and grignard reagents newly installed at Joban Plant

  • 1992
    Multi-purpose, small-amount manufacturing facilities newly installed at Joban Plant

  • 1995
    The Head Office moved to the current location
    A laboratory (Technological Development Center) newly established at Joban Plant
    DNA manufacturing facilities newly installed at Joban Plant

  • 1996
    The 2-vinylpyridine manufacturing facilities moved from Tokyo Laboratory to Joban Plant
    Joban Plant certified for ISO 9002.
    Manufacturing facilities dedicated to silicon- and grignard-related products newly installed at Joban Plant
    Capital increased to 3,471 million yen
    Started manufacture of trifluorothymidine

  • 1998
    The Head Office, Osaka Sales Office, Joban Plant and Tokyo Laboratory certified for ISO 9001
    Investigational drug testing research facilities newly installed at Joban Plant

  • 1999
    Certified for ISO 14001

  • 2001
    Started manufacture of Fudosteine “YUKI”
    Yuki Engineering Co., Ltd., an affiliated company, renamed “Yuki Techno Service Co., Ltd”
    Pharmaceutical manufacturing facilities newly installed at Joban Plant

  • 2003
    Selected as loanable stock
    Quality Control Building newly completed at Joban Plant.

  • 2004
    Listed on the First Section of the Tokyo Stock Exchange market
    Started operation of the enterprise resource planning system

  • 2006
    Dusseldorf Office established as an overseas office

  • 2007
    LNG conversion facilities newly established

  • 2012
    Started manufacture of active pharmaceutical ingredients for generics

  • 2014
    Cogeneration system introduced

  • 2018
    APIs and pharmaceutical intermediates manufacturing facilities installed at Joban Plant

  • 2021
    Certified for FSSC 22000

  • 2022
    Changed to the Standard Market of the Tokyo Stock Exchange

We meet diverse needs of customers.

Other Contents